Compare Enovix Corporation (ENVX) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs Relay Therapeutics Inc. Common Stock — how do they compare? Enovix Corporation trades at $2.45 (market cap $549.72M), while Relay Therapeutics Inc. Common Stock trades at $18.07 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 6.9× Enovix Corporation's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| ENVX | RLAY | |
|---|---|---|
Market Cap | $549.72M | $3.82B |
Volume | 6,635,687 | 4,332,079 |
Sector | Industrials | Health |
52-Week High | $13.19 | $20.75 |
52-Week Low | $2.50 | $6.03 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $611.42M | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.46, down 3.53% on the day, reflecting a bearish technical trend. The company is in a high-growth investment phase, with revenue growing to $36 million in 2026 but reporting significant losses. Recent news highlights a CEO transition and progress in battery manufacturing for defense and consumer electronics, while analyst consensus remains largely positive with a $10.75 price target.
The outlook is bifurcated: strong analyst buy ratings and institutional interest signal long-term potential, but high cash burn, persistent losses, and bearish technical indicators present substantial near-term risks. Investment hinges on successful commercialization and achieving profitability from current expansion efforts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
